Skip to content

Individualized detection of drug sensitivity in three dimensional culture of pancreatic cancer portal venous circulating tumor cells in vitrol

Individualized detection of drug sensitivity in three dimensional culture of pancreatic cancer portal venous circulating tumor cells in vitrol

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900023544
Enrollment
Unknown
Registered
2019-06-01
Start date
2019-06-01
Completion date
Unknown
Last updated
2019-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic cancer

Interventions

High risk experimental group:chemotherapy dependents on the detection result
High risk control group:Routine treatment
Low risk experiment group:chemotherapy dependents on the detection result
Low risk control group:Routine treatment

Sponsors

He'nan Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 85 Years

Inclusion criteria

Inclusion criteria: Patients who were admitted to the hepatobiliary and pancreatic surgery department of our hospital from January 2019 to June 2020, with clear clinical imaging or pathological diagnosis results, and who had not received chemotherapy and radiotherapy within 3 months, and were diagnosed as pancreatic cancer and received surgical treatment.

Exclusion criteria

Exclusion criteria: Patients who received preoperative chemoradiotherapy or other antitumor treatments; Postoperative pathology suggested other diseases in patients; Patients who refused to be enrolled and those whose data were incomplete.

Design outcomes

Primary

MeasureTime frame
overall survival;

Countries

China

Contacts

Public ContactTao Lianyuan

He'nan Provincial People's Hospital

tly2007tly@hotmail.com+86 13910386448

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026